Viewing Study NCT00408902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:42 AM
Study NCT ID: NCT00408902
Status: COMPLETED
Last Update Posted: 2017-11-22
First Post: 2006-12-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11
Start Date Type: None
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2008-12
Completion Date Type: ACTUAL
First Submit Date: 2006-12-06
First Submit QC Date: None
Study First Post Date: 2006-12-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-01-26
Results First Submit QC Date: None
Results First Post Date: 2015-02-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-10-19
Last Update Post Date: 2017-11-22
Last Update Post Date Type: ACTUAL